HATs off to Hop: Recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy

Journal of Clinical Investigation

Volumn 112, Issue 6, 2003, Pages 824-826

  Hamamori, Yasuo ^a   Schneider, Michael D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE I; HISTONE DEACETYLASE II; HISTONE DEACETYLASE INHIBITOR; HOMEODOMAIN ONLY PROTEIN; HOMEODOMAIN PROTEIN; UNCLASSIFIED DRUG; ACYLTRANSFERASE; ENZYME INHIBITOR; REPRESSOR PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN;

ACETYLATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HEART FAILURE; HEART HYPERTROPHY; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; CARDIOMEGALY; CLASSIFICATION; HEART MUSCLE; METABOLISM; NON-PROGRAMMATIC; NOTE;

NON-PROGRAMMATIC;

ACETYLTRANSFERASES; ANIMALS; CARDIOMEGALY; ENZYME INHIBITORS; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HOMEODOMAIN PROTEINS; MYOCARDIUM; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 0142186685     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319834     Document Type: Review

References (21)

1. Olson, E.N., and Schneider, M.D. 2003. Sizing up the heart: development redux in disease. Genes Dev. 17:1937-1956.
2. Zhang, C.L., et al. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 110:479-488.
3. Carrozza, M.J., Utley, R.T., Workman, J.L., and Cote, J. 2003. The diverse functions of histone acetyltransferase complexes. Trends Genet. 19:321-329.
4. Schreiber, S.L., and Bernstein, B.E. 2002. Signaling network model of chromatin. Cell. 111:771-778.
5. Grewal, S.I., and Moazed, D. 2003. Heterochromatin and epigenetic control of gene expression. Science. 301:798-802.
6. Yao, T.P., et al. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 93:361-372.
7. Baluchamy, S., Rajabi, H.N., Thimmapaya, R., Navaraj, A., and Thimmapaya, B. 2003. Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity. Proc. Natl. Acad. Sci. U. S. A. 100:9524-9529.
8. Imai, S., Armstrong, C.M., Kaeberlein, M., and Guarente, L. 2000 Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 403:795-800.
9. Chen, F., et al. 2002. Hop is an unusual homeobox gene that modulates cardiac development. Cell. 110:713-723.
10. Shin, C.H., et al. 2002. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell. 110:725-735.
11. Wang, D.Z., et al. 2002. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl. Acad. Sci. U. S. A. 99:14855-14860.
12. Miralles, F., Posern, G., Zaromytidou, A.I., and Treisman, R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 113:329-342.
13. Chang, D.F., et al. 2003. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell. 4:107-118.
14. Kook, H., et al. 2003. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 112:863-871. doi:10.1172/JCI200319137.
15. Antos, C.L., et al. 2003. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem. 278:28930-28937.
16. Marks, P.A., Richon, V.M., Breslow, R., and Rifkind, R.A. 2001. Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13:477-483.
17. Sano, M., and Schneider, M.D. 2002. Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload. Circulation. 105:8-10.
18. Shioi, T., et al. 2003. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation. 107:1664-1670.
19. Sano, M., et al. 2002. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat. Med. 8:1310-1317.
20. Sepulveda, J.L., Vlahopoulos, S., Iyer, D., Belaguli, N., and Schwartz, R.J. 2002. Combinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity. J. Biol. Chem. 277:25775-25782.
21. Davis, F.J., Gupta, M., Camoretti-Mercado, B., Schwartz, R.J., and Gupta, M.P. 2003. Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy. J. Biol. Chem. 278:20047-20058.